Thus, collecting lymphatic vessels appear to be a consistently and broadly affected by metabolic disease progression, and titrating the proper degree of VEGFR3 stimulation could be beneficial with synergetic effects as a therapeutic target between lymphatic network maintenance in initial lymphatics and promoting lymphatic contractility in collecting lymphatic. The gene discussed is FLT4; the disease is Other metabolic disease.